TY - JOUR
T1 - The 2015 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension
AU - Canadian Hypertension Education Program
AU - Daskalopoulou, Stella S.
AU - Rabi, Doreen M.
AU - Zarnke, Kelly B.
AU - Dasgupta, Kaberi
AU - Nerenberg, Kara
AU - Cloutier, Lyne
AU - Gelfer, Mark
AU - Lamarre-Cliche, Maxime
AU - Milot, Alain
AU - Bolli, Peter
AU - McKay, Donald W.
AU - Tremblay, Guy
AU - McLean, Donna
AU - Tobe, Sheldon W.
AU - Ruzicka, Marcel
AU - Burns, Kevin D.
AU - Vallée, Michel
AU - Ramesh Prasad, G. V.
AU - Lebel, Marcel
AU - Feldman, Ross D.
AU - Selby, Peter
AU - Pipe, Andrew
AU - Schiffrin, Ernesto L.
AU - McFarlane, Philip A.
AU - Oh, Paul
AU - Hegele, Robert A.
AU - Khara, Milan
AU - Wilson, Thomas W.
AU - Brian Penner, S.
AU - Burgess, Ellen
AU - Herman, Robert J.
AU - Bacon, Simon L.
AU - Rabkin, Simon W.
AU - Gilbert, Richard E.
AU - Campbell, Tavis S.
AU - Grover, Steven
AU - Honos, George
AU - Lindsay, Patrice
AU - Hill, Michael D.
AU - Coutts, Shelagh B.
AU - Gubitz, Gord
AU - Campbell, Norman R.C.
AU - Moe, Gordon W.
AU - Howlett, Jonathan G.
AU - Boulanger, Jean Martin
AU - Prebtani, Ally
AU - Larochelle, Pierre
AU - Leiter, Lawrence A.
AU - Jones, Charlotte
AU - Ogilvie, Richard I.
N1 - Funding Information:
The CHEP is operated and funded by Hypertension Canada. The members of the CHEP Committee are unpaid volunteers who contribute their time and expertise to the annual development and dissemination of the CHEP recommendations. To maintain professional credibility of the content, the process for the development of the recommendations is fully independent and free from external influence. External partners assist with the dissemination of the approved recommendations.
Publisher Copyright:
© 2015 Canadian Cardiovascular Society.
PY - 2015/5/1
Y1 - 2015/5/1
N2 - The Canadian Hypertension Education Program reviews the hypertension literature annually and provides detailed recommendations regarding hypertension diagnosis, assessment, prevention, and treatment. This report provides the updated evidence-based recommendations for 2015. This year, 4 new recommendations were added and 2 existing recommendations were modified. A revised algorithm for the diagnosis of hypertension is presented. Two major changes are proposed: (1) measurement using validated electronic (oscillometric) upper arm devices is preferred over auscultation for accurate office blood pressure measurement; (2) if the visit 1 mean blood pressure is increased but < 180/110 mm Hg, out-of-office blood pressure measurements using ambulatory blood pressure monitoring (preferably) or home blood pressure monitoring should be performed before visit 2 to rule out white coat hypertension, for which pharmacologic treatment is not recommended. A standardized ambulatory blood pressure monitoring protocol and an update on automated office blood pressure are also presented. Several other recommendations on accurate measurement of blood pressure and criteria for diagnosis of hypertension have been reorganized. Two other new recommendations refer to smoking cessation: (1) tobacco use status should be updated regularly and advice to quit smoking should be provided; and (2) advice in combination with pharmacotherapy for smoking cessation should be offered to all smokers. The following recommendations were modified: (1) renal artery stenosis should be primarily managed medically; and (2) renal artery angioplasty and stenting could be considered for patients with renal artery stenosis and complicated, uncontrolled hypertension. The rationale for these recommendation changes is discussed.
AB - The Canadian Hypertension Education Program reviews the hypertension literature annually and provides detailed recommendations regarding hypertension diagnosis, assessment, prevention, and treatment. This report provides the updated evidence-based recommendations for 2015. This year, 4 new recommendations were added and 2 existing recommendations were modified. A revised algorithm for the diagnosis of hypertension is presented. Two major changes are proposed: (1) measurement using validated electronic (oscillometric) upper arm devices is preferred over auscultation for accurate office blood pressure measurement; (2) if the visit 1 mean blood pressure is increased but < 180/110 mm Hg, out-of-office blood pressure measurements using ambulatory blood pressure monitoring (preferably) or home blood pressure monitoring should be performed before visit 2 to rule out white coat hypertension, for which pharmacologic treatment is not recommended. A standardized ambulatory blood pressure monitoring protocol and an update on automated office blood pressure are also presented. Several other recommendations on accurate measurement of blood pressure and criteria for diagnosis of hypertension have been reorganized. Two other new recommendations refer to smoking cessation: (1) tobacco use status should be updated regularly and advice to quit smoking should be provided; and (2) advice in combination with pharmacotherapy for smoking cessation should be offered to all smokers. The following recommendations were modified: (1) renal artery stenosis should be primarily managed medically; and (2) renal artery angioplasty and stenting could be considered for patients with renal artery stenosis and complicated, uncontrolled hypertension. The rationale for these recommendation changes is discussed.
UR - http://www.scopus.com/inward/record.url?scp=84928821188&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84928821188&partnerID=8YFLogxK
U2 - 10.1016/j.cjca.2015.02.016
DO - 10.1016/j.cjca.2015.02.016
M3 - Article
C2 - 25936483
AN - SCOPUS:84928821188
SN - 0828-282X
VL - 31
SP - 549
EP - 568
JO - Canadian Journal of Cardiology
JF - Canadian Journal of Cardiology
IS - 5
ER -